Lilly To Bolster IBD Pipeline With $3.2bn Morphic Bid

Jul 08 2024

• By Joseph Haas

Lilly will add oral integrins to its pipeline via $3.2bn bid for Morphic • Source: Shutterstock

More from Deals

More from Business